Abbott India Limited Stock

Equities

ABBOTINDIA

INE358A01014

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:50 2024-05-03 am EDT 5-day change 1st Jan Change
26,144 INR -1.73% Intraday chart for Abbott India Limited +1.08% +14.41%
Sales 2024 * 58.91B 706M Sales 2025 * 65.79B 789M Capitalization 556B 6.66B
Net income 2024 * 11.88B 142M Net income 2025 * 13.45B 161M EV / Sales 2024 * 9.05 x
Net cash position 2024 * 22.66B 272M Net cash position 2025 * 26.6B 319M EV / Sales 2025 * 8.04 x
P/E ratio 2024 *
46.6 x
P/E ratio 2025 *
41 x
Employees 3,700
Yield 2024 *
1.12%
Yield 2025 *
1.29%
Free-Float 24.52%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.73%
1 week+1.08%
Current month-1.03%
1 month-2.14%
3 months-6.84%
6 months+14.80%
Current year+14.41%
More quotes
1 week
25 801.70
Extreme 25801.7
26 898.95
1 month
25 200.05
Extreme 25200.05
27 260.00
Current year
22 750.50
Extreme 22750.5
29 628.15
1 year
20 594.25
Extreme 20594.25
29 628.15
3 years
15 223.10
Extreme 15223.1
29 628.15
5 years
7 150.00
Extreme 7150
29 628.15
10 years
1 705.00
Extreme 1705
29 628.15
More quotes
Managers TitleAgeSince
Chief Executive Officer - 94-12-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 68 19-03-31
Chairman 81 67-12-31
Director/Board Member 67 95-12-31
More insiders
Date Price Change Volume
24-05-03 26,144 -1.73% 246
24-05-02 26,604 +0.71% 286
24-04-30 26,416 +0.53% 251
24-04-29 26,278 +1.60% 446
24-04-26 25,865 +0.78% 269

Delayed Quote Bombay S.E., May 03, 2024 at 06:00 am EDT

More quotes
Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. ABBOTINDIA Stock